oncopeptides.se
OncopeptidesOncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.
http://www.oncopeptides.se/
Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.
http://www.oncopeptides.se/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2.9 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
10
SSL
EXTERNAL LINKS
5
SITE IP
46.253.206.49
LOAD TIME
2.906 sec
SCORE
6.2
Oncopeptides | oncopeptides.se Reviews
https://oncopeptides.se
Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.
oncopeptides.se
Investors – Oncopeptides
https://www.oncopeptides.se/about/investors
Phone: 46 8 442 58 50. HealthCap is a family of multi stage venture capital funds, investing globally in life sciences. With more than 1 billion raised since the start in 1996, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe. Phone: 46 8-587 919 00. Industrifonden offers venture capital, competence and a network of contacts to small and medium-sized companies with international growth potential.
News – Oncopeptides
https://www.oncopeptides.se/news
Oncopeptides prepare for pivotal Phase 3 clinical trials. Oncopeptides have a successful meeting with MHRA. Oncopeptides CEO Jakob Lindberg featured in the latest Monocl blog about multiple myeloma. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients. Oncopeptides Secures Venture Funding for Phase II Trial of Melflufen in Multiple Myeloma Patients.
Founders – Oncopeptides
https://www.oncopeptides.se/about/founders
Rolf Larsson, MD, PhD, Professor of Clinical Pharmacology. Rolf Lewensohn, MD, PhD, Professor of Oncology. Joachim Gullbo, MD, PhD, MSc Pharm, Associate Consultant in Oncology. Kristina Luthman, PhD, Professor of Medicinal Chemistry. At Gothenburg University. The focus of Dr Luthman’s research is in the field of design and synthesis of peptides and peptidomimetics with various biological activities, e.g. cytotoxic activities. Another research interest is the identification of molecu...Hans Ehrsson, MD, P...
Board – Oncopeptides
https://www.oncopeptides.se/about/board
Alan Hulme was appointed as Chairman of the Board in April 2010. In addition to his activities with Oncopeptides he works across Europe with other development stage client companies in the Life Sciences sector, providing corporate development consultancy services through TechGen International Ltd, London. Mr Hulme has been located for extensive periods in the Far East, the US (East Coast, West Coast and mid-West) and with secondments in Europe – UK, Germany, France and Norway. Jonas Brambeck, PhD. Jarl U...
Business Development – Oncopeptides
https://www.oncopeptides.se/business-development/business-strategy
Business Strategy and Partnering. The demand for more efficacious drugs to target cancer is considerable, and both the efficacy and the preferential targeting of malignant cells shown by Oncopeptides with melflufen, indicates the potential for significant medical benefit over existing basic chemotherapeutic compounds currently in use. If you would like to discuss business opportunities with Oncopeptides please contact our CEO, Jakob Lindberg. Or our Head of Business Development, Björn Hammarberg.
TOTAL PAGES IN THIS WEBSITE
10
Portfolio Companies - HealthCap
http://www.healthcap.eu/the-investments
Senior and Special Advisors. Actelion is a Swiss biopharmaceutical company focusing on pulmonary arterial hypertension (PAH). The company listed on the Swiss Stock Exchange in 2000. Aerocrine is a medical technology company that develops and commercializes unique, easy-to-use and tailored products for the measurement of nitric oxide (NO) as an inflammatory marker for patients with inflammatory disorders, such as asthma. Aerocrine listed on the Nasdaq OMX Stockholm stock exchange in 2007. Altimmune is a c...
Kunder jag jobbar/har jobbat med | Maritha Lundin
http://marithalundin.se/kunder
Nedan hittar ni några av de kunder jag jobbat med. Är idag anställd på Gyros AB. Storsjökök i Uppsala AB. Alpa El and Fordonsservice.
Investments - HealthCap
http://www.healthcap.eu/investments
Senior and Special Advisors. Actelion is a Swiss biopharmaceutical company focusing on pulmonary arterial hypertension (PAH). The company listed on the Swiss Stock Exchange in 2000. Aerocrine is a medical technology company that develops and commercializes unique, easy-to-use and tailored products for the measurement of nitric oxide (NO) as an inflammatory marker for patients with inflammatory disorders, such as asthma. Aerocrine listed on the Nasdaq OMX Stockholm stock exchange in 2007. Altimmune is a c...
Alumn companies | KI Science Park
http://sciencepark.ki.se/foretag-parken/alumnforetag
Companies in the park. View by therapeutic area. Companies in business incubator. Science Park Companies in the Media. Svenska) Tidigare nyhetsbrev – arkiv. Life Science specific support functions. Karolinska Institutet Science Park DAY. TPP The Company Compass. Karolinska Institutet Science Park DAY. How to find us. Aktivia Science Work AB. Karolinska Institutet University Press AB. Söderström and Partners AB. KAROLINSKA INSTITUTET SCIENCE PARK AB 2013.
TOTAL LINKS TO THIS WEBSITE
5
OncoPDA – hematology and oncology web apps
Darr; Skip to Main Content. The future is mobile and the future is multi-platform. With that, OncoPDA has been revamped, focusing on mobile medical web apps. The advantage of these apps are that they are platform independent and can run on iOS, Android and even your desktop browser. These are apps based on HTML5 technology and can run offline like a regular app on your smartphone or iPad provided you save it as a shortcut on your Home screen. Tips on using this site. Check out the apps from our General.
Oncoped | Oncología pediátrica
044) 55 5402 0955. Dr Carlos A Leal. Dr Carlos A. Leal. Diagnóstico, tratamiento, evaluación y seguimiento. Diagnóstico, tratamiento, evaluación y seguimiento. Acerca del Dr. Carlos A. Leal. 044) 55 5402 0955. Viaducto Río Becerra 97-desp 311 Colonia Nápoles, Ciudad de Mèxico, México, C.P. 03810. Diseño de página por Neoweb.
Tratamiento infantil de enfermedades oncologicas y hematologicas
Organización de la Unidad. Trasplante autólogo de médula. El niño y su familia. Oncología Pediátrica 902107469 Hematología Pediátrica 902089800. 34 639 713 145. Unidad de Hematología y Oncología Pediátrica. La unidad de Hematología y Oncología Pediátrica del Grupo HM, y que dirige la. Con la Dra. Marta Villa. Como jefe clínico, está ubicada en el Hospital Universitario HM Monteprincipe. Y con HM Hospitales. Unidad de Hematología y Oncopediatria. Cómo lo estamos haciendo. El próximo 29 de noviembre a las ...
الرئيسية - برنامج محمد بن راشد للتعلم الذكي
برنامج محمد بن راشد للتعلم الذكي. برنامج التعلم الذكي هي مبادرة أطلقها الشيخ محمد بن راشدآل مكتوم في أبريل 2012، والتي تهدف إلى تطوير بيئةلدعم إصلاح التعليم في دولة الإمارات العربية المتحدة. وهي موجهة لجميع المدارس الحكوميةالتابعة لوزارة التربية والتعليم من خلال خطة تمهيديةلفترة خمس سنوات. تم تطوير العام الماضي 450 محتوى تعليمي الكتروني وفقا للمنهج الدراسي للصف السابع. المشروع الحالي يهدف إلى تطوير 870 محتوى تعليمي الكتروني للصف الثامن.
OncoPep
FOR THE TREATMENT OF CANCER. OncoPep is developing PVX-410,. An investigational cancer vaccine designed to stop disease progression in multiple myeloma. In addition to smoldering multiple myeloma (SMM), our investigational peptide portfolio more broadly targets multiple myeloma, triple negative breast cancer (TNBC) and several solid cancer tumors (breast, colon, pancreatic, prostate). Our initial clinical focus is to halt disease progression in SMM and TNBC. Learn More ABOUT SMM and MM. 520 Boston Street,.
Oncopeptides
Investors and media contact. Annual General Meeting 2018. The Board of Directors. Work of the Board of Directors. CEO Jakob Lindberg on Oncopeptides and Ygalo. Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients. Was published on February 22, 2018. Read the full report. April 12, 2018. First patient starts treatment in Oncopeptides’ Phase I / II ANCHOR study with Ygalo. March 29, 2018. March 26, 2018. May 17, 2018.
ONCOPET - Oncologia Veterinária
Eacute; esse o principal objetivo do Oncopet, nossa missão é ajudar os proprietários de cães e gatos a darem qualidade de vida aos pacientes Oncológicos. O Oncopet é formado por uma equipe de profissionais especializados na área de Oncologia Veterinária que fazem atendimento em diversas Clínicas e Hospitais no Estado de São Paulo. Oncopet - Todos os Direitos Reservados - www.oncopet.com.br. Powered by Interativa - www.grupointerativa.com.br - Tel.:(12) 3633.8202.
保険に見直しはつきものだから定期的に相談をする
Posted by oncopetdiagnostics.com. On 3月 - 5 - 2014. 一般的に、保険というのは 難しいもの 勧誘がしつこいもの のようなイメージがあります。 なぜ、一度加入した保険を見直さないといけないのでしょう その理由を一言で言うと、 状況が変わるから です。 自転車保険に入っておけば安心です ここをチェックしてみてください ネットde保険 さいくる. Designed by: Quality Hosting. Contributions by: Vertalen Nederlands Frans.
UNAC
2012 Oncopets - UNAC. Todos los Derechos Reservados. Creado por AMS media. Tel.: 83-56-95-99, 83-78-21-88 y 41-96.
Oncopet | Home
Oncopet e os Animais. É a primeira clínica em nosso estado, e uma das únicas do país. A oferecer tratamento radioterápico para animais. Além disso, oferece diversos serviços como atendimento clínico geral, atendimento oncológico especializado, quimioterapia, eletroquimioterapia e cirurgias para cães e gatos. Leia mais ». A clínica também recebe casos encaminhados por outros profissionais para suporte no diagnóstico e tratamento de tumores, sempre preservando nosso compromisso ético. Leia mais ».
